KSQ THERAPEUTICS INC has a total of 33 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are GUANGZHOU ZHAOTAI INVIVO BIOMEDICINE CO LTD, B MOGEN BIOTECHNOLOGIES INC and EXUMA BIOTECH CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 3 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | EPO (European Patent Office) | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Heterocyclic compounds | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Schlabach Michael | 29 |
#2 | Benson Micah | 25 |
#3 | Shenker Solomon Martin | 24 |
#4 | Merkin Jason | 24 |
#5 | Tubo Noah | 23 |
#6 | Kryukov Gregory V | 23 |
#7 | Kaberna Ii James Martin | 7 |
#8 | Brenneman Jehrod Burnett | 3 |
#9 | Michael Schlabach | 3 |
#10 | Micah Benson | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020237040A1 | Nr4a super-repressors and methods of use thereof | |
WO2020163365A2 | Combination gene targets for improved immunotherapy | |
WO2020160489A1 | Gene-regulating compositions and methods for improved immunotherapy | |
WO2020132269A1 | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (usp1) inhibitors | |
CN112040987A | Gene regulatory compositions and methods for improved immunotherapy | |
CA3093968A1 | Gene-regulating compositions and methods for improved immunotherapy | |
EP3765094A1 | Gene-regulating compositions and methods for improved immunotherapy | |
CN112040986A | Gene regulatory compositions and methods for improved immunotherapy |